Our results highlight the heterogeneity of EGFR, CDK4, MDM4, and PDGFRA gene expression profiles in GBM, which can only be partially explained by underlying gene amplification and/or intragenic deletions, revealing the complexity of the mechanisms involved in overexpression of these genes in individual GBM. The gene discussed is CDK4; the disease is glioblastoma.